Back

Timing of initiation of sodium-glucose co-transporter 2 inhibitor in patients with diabetes and chronic cardiac failure

26 August 2022 (10:15 - 11:00)
Organised by:
Congress Presentation Part of: Chronic heart failure and diabetes Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Wen Sun

The Chinese University of Hong Kong, Shatin (Hong Kong)

5 More presentations in this session

Presentation thumbnail
Biomarker profiles and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome
Miss C. van der Hoef (Groningen, NL)
Abstract Slides
Presentation thumbnail
Diabetes may modify the efficacy of primary prevention implantable cardioverter-defibrillators in non-ischemic systolic heart failure: an extended follow-up of the DANISH trial
Doctor S. N Doi (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Prediabetes relates to impaired mitochondrial function in human ventricular myocardium
Mr E. Zweck (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Outcomes in hospitalised diabetic ketoacidosis patients with underlying heart failure: a national inpatient sample analysis
Doctor S. Yalamanchili (Greenville, US)
Abstract Slides
Presentation thumbnail
Risk of heart failure following short-term non-steroidal anti-inflammatory drug use in patients with type 2 diabetes mellitus
Mr J. Strange (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure and diabetes

The Event

Event poster

ESC Congress 2022

26 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources